PTC India's Net Profit Rises 16% in Q2
By Rediff Money Desk, New Delhi Nov 12, 2024 19:48
PTC India reported a 16% increase in consolidated net profit to Rs 233.82 crore in the September quarter, driven by higher revenues. Read more.
New Delhi, Nov 12 (PTI) Power trading solutions provider PTC India on Tuesday posted a nearly 16 per cent rise in its consolidated net profit to Rs 233.82 crore in the September quarter compared to the year-ago period on the back of higher revenues.
The company had reported a consolidated net profit of Rs 202.31 crore in the quarter ended on September 30, 2023, a BSE fling showed.
Total income rose to Rs 5,133.63 crore in the quarter from Rs 5,088.29 crore in the same period a year ago.
The Board of Directors of the company in its meeting held on November 12, 2024, approved the appointment of Rajneesh Agarwal as the nominee director of NHPC Ltd on the board, the filing stated.
The company had reported a consolidated net profit of Rs 202.31 crore in the quarter ended on September 30, 2023, a BSE fling showed.
Total income rose to Rs 5,133.63 crore in the quarter from Rs 5,088.29 crore in the same period a year ago.
The Board of Directors of the company in its meeting held on November 12, 2024, approved the appointment of Rajneesh Agarwal as the nominee director of NHPC Ltd on the board, the filing stated.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 8.08 ( -3.92)
- 65128261
- Thinkink Picturez
- 1.77 ( -0.56)
- 47207415
- Sunshine Capital
- 2.32 (+ 4.98)
- 18775443
- Evexia Lifecare
- 4.07 (+ 3.30)
- 16083406
- Cressanda Railway
- 11.19 (+ 4.97)
- 15151945
MORE NEWS
India Pushes for Fast-Track WTO Talks on...
India has called for expedited negotiations in the WTO on the Special Safeguard...
Sensex Surges 809 Points Ahead of RBI Policy
The BSE Sensex rallied 809 points on Thursday, led by IT stocks, ahead of the RBI's...
Aurobindo Pharma Gets USFDA Approval for...
Aurobindo Pharma's subsidiary, Eugia Pharma Specialities, has received USFDA approval...